Novel Heuristic Parameters in Coronary Artery Disease Prevention and Treatment
Article Sidebar
Main Article Content
Abstract
There are many factors associated with the incidence and progression of coronary artery disease. Still, the exact mechanisms and pathophysiology are not clearly understood. The process of atherosclerosis remains an enigma, though some basic mechanisms and pathophysiology are known. There are some risk factors associated with clinical conditions that appear protective based on clinical experience. Heuristically, the weightage and performance are represented by the equations. The factors include chronic obstructive lung disease, chronic liver diseases, cataract formation, and chronic renal failure, where the incidence and progression are slower. However, further mechanisms, such as hypoxic-ischemic growth factors with downstream vascular endothelial growth factors (VEGF) and insulin-like growth factors (IGF-1), serum estrogen levels, dystrophic calcification mechanisms, and parathyroid hormone- or calcium-related metabolism through 1,25-dihydroxycholecalciferol, could also play an active role in the etiopathogenesis. Understanding and utilising the underlying pathophysiology and mechanisms can be highly productive for the prevention, progression, and further treatment of coronary artery disease, as well as for future research.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
[1] Nemet, A., Vinker, S., Levartovsky, S. et al. Is cataract associated with cardiovascular morbidity?. Eye24, 1352–1358 (2010). https://doi.org/10.1038/eye.2010.34
[2] Klein R, Moss SE, Klein BE, DeMets DL . Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 1989; 149: 266–272.
[3] Ekström C, Grunditz Ustrup J. Association between Age-related Cataract and Mortality in Sweden: A Long-term Population-based Follow-up Study. Epidemiol [Internet]. 2020, DOI: 10.1080/09286586.2020.1839913.
[4] Kim JY, Chung HS, Lee JS, Lee H, Tchah H. Relationship between Cataract Surgery and Mortality in Elderly Patients with Cataract: Nationwide Population-Based Cohort Study in South Korea. J Pers Med. 2021 Nov 1;11(11):1128. doi: 10.3390/jpm11111128.
[5] Ezhilarasan D. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary Pancreat Dis Int. 2020 Oct;19(5):429-434. doi: 10.1016/j.hbpd.2020.03.011. Epub 2020 Apr 8. PMID: 32299655.
[6] Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML; WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007 Jun 21;356(25):2591-602. doi: 10.1056/NEJMoa071513. PMID: 17582069.
[7] Peng, YQ., Xiong, D., Lin, X. et al. Oestrogen Inhibits Arterial Calcification by Promoting Autophagy. Sci Rep 7, 3549 (2017). https://doi.org/10.1038/s41598-017-03801-x
[8] Milica Bozic, Juan M Diaz-Tocados, Marcelino Bermudez-Lopez, Carles Forné, Cristina Martinez, Elvira Fernandez, José M Valdivielso, Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort, Nephrology Dialysis Transplantation, Volume 37, Issue 4, April 2022, Pages 663–672, https://doi.org/10.1093/ndt/gfab184.
[9] Saha S, Narang R, Goswami R, Pandey NN, Sharma V, Kalaivani M, Sen S, Kandasamy D, Chandran DS, Deepak KK. Coronary artery disease and its vascular associates in patients with chronic nonsurgical hypoparathyroidism. Clin Endocrinol (Oxf). 2023 Apr;98(4):505-515. doi: 10.1111/cen.14872. Epub 2023 Jan 1. PMID: 36567495.
[10] Gautam R Shroff, Michelle D Carlson, Roy O Mathew. Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart–Kidney Team-Based Approach. European Cardiology Review 2021;16:e48. https://doi.org/10.15420/ecr.2021.30.
[11] Fujimoto, Daichi et al. Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina. Atherosclerosis, Volume 405, 119237.
[12] Thomas IC, Forbang NI, Criqui MH. The evolving view of coronary artery calcium and cardiovascular disease risk. Clin Cardiol. 2018 Jan;41(1):144-150. doi: 10.1002/clc.22842. Epub 2018 Jan 22. PMID: 29356018; PMCID: PMC6020678.
[13] Kang SY, Deshpande SS, Donneys A, Rodriguez JJ, Nelson NS, Felice PA, Chepeha DB, Buchman SR. Parathyroid hormone reverses radiation induced hypovascularity in a murine model of distraction osteogenesis. Bone. 2013 Sep;56(1):9-15. doi: 10.1016/j.bone.2013.04.022. Epub 2013 May 1.
[14] Ding Q, Sun P, Zhou H, Wan B, Yin J, Huang Y, Li Q, Yin G, Fan J. Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factor mediated angiogenesis. Int J Mol Med. 2018 Jul;42(1):171-181. doi: 10.3892/ijmm.2018.3614. Epub 2018 Apr 3.
[15] Dhillon RS, Xie C, Tyler W, Calvi LM, Awad HA, Zuscik MJ, O'Keefe RJ, Schwarz EM. PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis. J Bone Miner Res. 2013 Mar;28(3):586-97. doi: 10.1002/jbmr.1765.
[16] Panh L, Lairez O, Ruidavets JB, Galinier M, Carrié D, Ferrières J. Coronary artery calcification: From crystal to plaque rupture. Arch Cardiovasc Dis. 2017 Oct;110(10):550-61. Available from: https://doi.org/10.1016/j.acvd.2017.04.003
[17] Ferencik M, Schlett CL, Ghoshhajra BB, et al. A computed tomography‐based coronary lesion score to predict acute coronary syndrome among patients with acute chest pain and significant coronary stenosis on coronary computed tomographic angiogram. Am J Cardiol. 2012;110:183–189.
[18] Kolossváry M, Szilveszter B, Merkely B, Maurovich-Horvat P. Plaque imaging with CT—a comprehensive review on coronary CT angiography based risk assessment. Cardiovasc Diagn Ther 2017;7(5):489-506. doi: 10.21037/cdt.2016.11.06
[19] Ahmadi N, Nabavi V, Hajsadeghi F, et al. Mortality incidence of patients with non‐obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol. 2011;107:10–16.
[20] Hou ZH, Lu B, Gao Y, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012;5:990–999.
[21] Sung D-E, Sung K-C. The Paradox of Physical Activity and Coronary Artery Calcification: Implications for Cardiovascular Risk. Journal of Clinical Medicine. 2024; 13(21):6523. https://doi.org/10.3390/jcm13216523
[22] Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750524. doi: 10.1177/1753465817750524. PMID: 29355081; PMCID: PMC5937157.
[23] Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65: 956–962.
[24] Mallet RT, Burtscher J, Richalet JP, Millet GP, Burtscher M. Impact of High Altitude on Cardiovascular Health: Current Perspectives. Vasc Health Risk Manag. 2021 Jun 8;17:317-335. doi: 10.2147/VHRM.S294121. PMID: 34135590; PMCID: PMC8197622.
[25] Avellanas Chavala ML. A journey between high altitude hypoxia and critical patient hypoxia: What can it teach us about compression and the management of critical disease? Med Intensiv. 2018 Aug;42(6):380-90. Available from: https://doi.org/10.1016/j.medine.2018.05.013
[26] Bakleh MZ, Al Haj Zen A. The Distinct Role of HIF-1α and HIF-2α in Hypoxia and Angiogenesis. Cells. 2025; 14(9):673. https://doi.org/10.3390/cells14090673